Biologics APIs

Mar 26, 2018
By Pharmaceutical Technology Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By Pharmaceutical Technology Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By Pharmaceutical Technology Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 08, 2018
By Pharmaceutical Technology Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Mar 08, 2018
By Pharmaceutical Technology Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Mar 08, 2018
The FDA commissioner outlined the agency's initiatives to reward innovation and biosimilars development.
Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 07, 2018
By Pharmaceutical Technology Editors
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
Feb 02, 2018
Pharmaceutical Technology
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
Jan 12, 2018
By Pharmaceutical Technology Editors
The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.
native1_300x100
lorem ipsum